bullish

Ainos

Ainos, Inc: WTR Small-Cap Spotlight Recap - Veldona Drug Platform and Clinical Studies

302 Views25 Oct 2024 18:34
Issuer-paid
Jack Lu, Director of Corporate Development, joined us on the WTR Small-Cap Spotlight podcast to discuss Veldona, Ainos’ clinical stage low-dose interferon-α (IFN-α)  therapeutic.
What is covered in the Full Insight:
  • Introduction
  • Overview of Veldona
  • Clinical History and Studies
  • Market Opportunities in Human and Animal Health
  • Regulatory and Development Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Water Tower Research
Research from Water Tower Research
Water Tower Research
Equity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x